Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of CellCept.
Phase of Trial: Phase II
Latest Information Update: 27 May 2016
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 20 Oct 2008 Status changed from active, no longer recruiting to completed.
- 09 Jan 2008 New trial record.